Hyperthyroidism Serum

About Hyperthyroidism Serum

Human Hyperthyroidism Serum for Thyroid Endocrinology Research

Our Hyperthyroidism Serum is sourced from IRB-consented donors clinically diagnosed with hyperthyroidism. Each sample is processed and frozen within 24 hours of collection to keep thermolabile hormones and binding proteins consistent from lot to lot. Serum is the conventional matrix for thyroid function testing, and because it is acellular it is supplied here for hormone immunoassay, serology, proteomic and metabolomic work rather than any cell-based application.

Why Hyperthyroidism Serum for Endocrine Research

Hyperthyroidism is a state of thyroid hormone excess. Whatever the underlying cause, the defining physiology is elevated circulating thyroid hormone with negative feedback suppression of pituitary thyroid-stimulating hormone, and a cascade of downstream metabolic effects. All of the primary readouts are soluble serum analytes.

• Core thyroid function panel — suppressed TSH with elevated free T4 and free T3 is the biochemical signature of overt hyperthyroidism; suppressed TSH with normal free hormones defines the subclinical state.
• Total versus free hormone and binding proteins — thyroxine-binding globulin, albumin and transthyretin govern the free fraction, making serum the right matrix for equilibrium and free-hormone assay development.
• Peripheral markers of hormone excess — sex hormone-binding globulin, bone turnover markers and lipid parameters shift in a direction characteristic of thyrotoxicosis and provide functional confirmation of hormone action.
• Thyroid-specific serology as a stratifier — TSH receptor antibody (TRAb) and thyroid-stimulating immunoglobulin (TSI), along with anti-TPO and anti-thyroglobulin antibodies, are measurable in serum and are used here to define subgroups rather than to assert a single mechanism.
• Thyroglobulin and calcitonin — thyroid-derived proteins in serum support assay development and interference testing in thyroid diagnostics.
• Treatment pharmacodynamics — antithyroid drug therapy, radioiodine and thyroidectomy each move the hormone panel in characteristic directions, allowing on-treatment reference material to be sourced.

Donor Stratification Available

• Biochemical severity — overt hyperthyroidism versus subclinical hyperthyroidism at the time of draw
• Underlying aetiology — Graves’ disease, toxic nodular goitre or toxic adenoma, and thyroiditis-associated thyrotoxicosis, subject to documentation
• Thyroid serology — TRAb/TSI-positive and TRAb-negative donors; anti-TPO and anti-thyroglobulin antibody status
• Treatment status — untreated, on thionamide antithyroid drugs, post-radioiodine, or post-thyroidectomy donors
• Clinical features and comorbidity — thyroid eye disease, atrial fibrillation, goitre, and pregnancy-associated presentations subject to availability
• Matched healthy controls available, euthyroid and matched for age, sex and ethnicity; hypothyroid comparator donors also available

Product Features

• Collected from clinically confirmed hyperthyroidism donors
• Research Use Only (RUO)
• Processed and frozen within 24 hours of collection
• IRB-approved protocols with documented consent
• Standard and custom aliquot volumes; volumes reported per lot

De-identified Donor Data

• Diagnosis confirmation
• Age, sex assigned at birth, and ethnicity
• Donor-reported medical history and comorbidities
• Thyroid function and serology results reported per lot where captured
• Additional thyroid-specific clinical fields available on request

Applications

• TSH, free T4 and free T3 immunoassay development, calibration and validation
• Free-hormone and binding-protein equilibrium method comparison
• TRAb, TSI, anti-TPO and anti-thyroglobulin serology assay development
• Thyroglobulin assay development and heterophile interference testing
• Metabolic consequence studies including lipid, SHBG and bone-turnover marker profiling
• Serum proteomic and metabolomic discovery in thyroid hormone excess
• Diagnostic reference, calibrator and control material sourcing for thyroid panels
• Therapeutic candidate screening and pharmacodynamic readout development

Other Hyperthyroidism Specimen Types

• Hyperthyroidism Plasma
• Hyperthyroidism PBMC
• Hyperthyroidism Whole Blood
• Hyperthyroidism Leukopak

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11-compliant e-signatures
• Documentation support available for regulatory review

Ordering & Customization

Hyperthyroidism serum is available in standard and custom volumes. For pricing, international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations. To compare collection formats or check wider availability, visit our human serum page.